The market is trading at some of the most overvalued levels in 20 years. Over the next five years, analysts expect 5% CAGR returns from the S&P 500.
That’s about 1/3 of what investors have enjoyed for the last decade. But it’s a market of stocks, not a stock market, and incredible bargains are always available.
Today this pharma spin-off is 66% undervalued, the best bargain worth buying on Wall Street. Analysts expect 29% CAGR total returns over the next 5 years.
This high-yield global dividend aristocrat is the best blue-chip bargain on Wall Street offering almost 20% CAGR consensus total return potential over the next five years. This is why I’ve invested $100K and counting into this global aristocrat Super SWAN.
This final company is the best hyper-growth blue-chip bargain, offering over 300% return potential over the next five years, which is why I’ve bought $90,000 of it for my retirement portfolio.
In total, I’ve invested nearly $200,000 into these three companies, because as Buffett said “When it’s raining gold, reach for a bucket, not a thimble.”